Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California. more
Time Frame | EKSO | Sector | S&P500 |
---|---|---|---|
1-Week Return | 2.36% | -2.12% | -3% |
1-Month Return | -19.32% | -3.42% | -0.73% |
3-Month Return | -52.06% | -11.13% | 2.87% |
6-Month Return | -43.68% | -5.74% | 7.17% |
1-Year Return | -65.47% | 3.97% | 25.31% |
3-Year Return | -81.17% | 1.05% | 28.38% |
5-Year Return | -90.08% | 34.37% | 81.89% |
10-Year Return | -99.56% | 97.88% | 183.27% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 13.92M | 8.88M | 11.25M | 12.91M | 18.28M | [{"date":"2019-12-31","value":76.14,"profit":true},{"date":"2020-12-31","value":48.59,"profit":true},{"date":"2021-12-31","value":61.52,"profit":true},{"date":"2022-12-31","value":70.64,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 7.15M | 3.81M | 4.50M | 6.70M | 9.20M | [{"date":"2019-12-31","value":77.75,"profit":true},{"date":"2020-12-31","value":41.43,"profit":true},{"date":"2021-12-31","value":48.88,"profit":true},{"date":"2022-12-31","value":72.8,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 6.76M | 5.07M | 6.75M | 6.21M | 9.08M | [{"date":"2019-12-31","value":74.5,"profit":true},{"date":"2020-12-31","value":55.84,"profit":true},{"date":"2021-12-31","value":74.34,"profit":true},{"date":"2022-12-31","value":68.44,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 48.60% | 57.08% | 60.01% | 48.13% | 49.67% | [{"date":"2019-12-31","value":80.99,"profit":true},{"date":"2020-12-31","value":95.12,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":80.19,"profit":true},{"date":"2023-12-31","value":82.76,"profit":true}] |
Operating Expenses | 23.40M | 17.93M | 20.58M | 21.77M | 24.19M | [{"date":"2019-12-31","value":96.74,"profit":true},{"date":"2020-12-31","value":74.11,"profit":true},{"date":"2021-12-31","value":85.06,"profit":true},{"date":"2022-12-31","value":89.99,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (16.64M) | (12.86M) | (13.83M) | (15.56M) | (15.11M) | [{"date":"2019-12-31","value":-1663900000,"profit":false},{"date":"2020-12-31","value":-1285800000,"profit":false},{"date":"2021-12-31","value":-1382800000,"profit":false},{"date":"2022-12-31","value":-1555600000,"profit":false},{"date":"2023-12-31","value":-1511200000,"profit":false}] |
Total Non-Operating Income/Expense | 3.03M | (3.44M) | 3.95M | 320.00K | (388.00K) | [{"date":"2019-12-31","value":76.61,"profit":true},{"date":"2020-12-31","value":-86.94,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":8.1,"profit":true},{"date":"2023-12-31","value":-9.82,"profit":false}] |
Pre-Tax Income | (12.13M) | (15.82M) | (9.76M) | (15.08M) | (15.20M) | [{"date":"2019-12-31","value":-1213200000,"profit":false},{"date":"2020-12-31","value":-1582500000,"profit":false},{"date":"2021-12-31","value":-976400000,"profit":false},{"date":"2022-12-31","value":-1508000000,"profit":false},{"date":"2023-12-31","value":-1519800000,"profit":false}] |
Income Taxes | (438.00K) | 1.13M | (1.33M) | (476.00K) | 1.53M | [{"date":"2019-12-31","value":-28.63,"profit":false},{"date":"2020-12-31","value":73.79,"profit":true},{"date":"2021-12-31","value":-87.05,"profit":false},{"date":"2022-12-31","value":-31.11,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | (11.69M) | (16.95M) | (8.43M) | (14.60M) | (16.73M) | [{"date":"2019-12-31","value":-1169400000,"profit":false},{"date":"2020-12-31","value":-1695400000,"profit":false},{"date":"2021-12-31","value":-843200000,"profit":false},{"date":"2022-12-31","value":-1460400000,"profit":false},{"date":"2023-12-31","value":-1672810500,"profit":false}] |
Income From Continuous Operations | (12.13M) | (15.82M) | (9.76M) | (15.08M) | (15.16M) | [{"date":"2019-12-31","value":-1213200000,"profit":false},{"date":"2020-12-31","value":-1582500000,"profit":false},{"date":"2021-12-31","value":-976400000,"profit":false},{"date":"2022-12-31","value":-1508000000,"profit":false},{"date":"2023-12-31","value":-1516200000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (11.69M) | (16.95M) | (8.43M) | (14.60M) | (15.20M) | [{"date":"2019-12-31","value":-1169400000,"profit":false},{"date":"2020-12-31","value":-1695400000,"profit":false},{"date":"2021-12-31","value":-843200000,"profit":false},{"date":"2022-12-31","value":-1460400000,"profit":false},{"date":"2023-12-31","value":-1519800000,"profit":false}] |
EPS (Diluted) | (2.36) | (2.50) | (0.91) | (1.16) | (1.10) | [{"date":"2019-12-31","value":-235.95,"profit":false},{"date":"2020-12-31","value":-250,"profit":false},{"date":"2021-12-31","value":-91,"profit":false},{"date":"2022-12-31","value":-116,"profit":false},{"date":"2023-12-31","value":-110,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
EKSO | |
---|---|
Cash Ratio | 1.10 |
Current Ratio | 2.81 |
Quick Ratio | 2.14 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
EKSO | |
---|---|
ROA (LTM) | -24.17% |
ROE (LTM) | -73.89% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
EKSO | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.49 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.51 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
EKSO | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.72 |
P/B | 0.96 |
Price/FCF | NM |
EV/R | 0.69 |
EV/Ebitda | 0.46 |
PEG | NM |
Ekso Bionics Holdings Inc (EKSO) share price today is $0.5801
Yes, Indians can buy shares of Ekso Bionics Holdings Inc (EKSO) on Vested. To buy Ekso Bionics Holdings Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in EKSO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Ekso Bionics Holdings Inc (EKSO) via the Vested app. You can start investing in Ekso Bionics Holdings Inc (EKSO) with a minimum investment of $1.
You can invest in shares of Ekso Bionics Holdings Inc (EKSO) via Vested in three simple steps:
The 52-week high price of Ekso Bionics Holdings Inc (EKSO) is $3.13. The 52-week low price of Ekso Bionics Holdings Inc (EKSO) is $0.5.
The price-to-earnings (P/E) ratio of Ekso Bionics Holdings Inc (EKSO) is
The price-to-book (P/B) ratio of Ekso Bionics Holdings Inc (EKSO) is 0.96
The dividend yield of Ekso Bionics Holdings Inc (EKSO) is 0.00%
The market capitalization of Ekso Bionics Holdings Inc (EKSO) is $14.21M
The stock symbol (or ticker) of Ekso Bionics Holdings Inc is EKSO